Description
Aquagest is a progesterone-based medication manufactured by Nuvista Pharma Ltd. in Bangladesh. It contains 25 mg of micronized progesterone per 1.119 mL ampoule and is administered via subcutaneous (SC) injection. Aquagest is primarily used to support early pregnancy in women undergoing assisted reproductive technologies like in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). It is also utilized in hormone replacement therapy (HRT) to prevent endometrial hyperplasia in women with an intact uterus receiving estrogen therapy
.jpeg)
.jpeg)
.jpeg)
Change Language